Title: The cytoprotective action of the potassium channel opener BMS-191095 in C2C12 myoblasts is related to the modulation of calcium homeostasis.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101
Title: ROS-independent preconditioning in neurons via activation of mitoK(ATP) channels by BMS-191095.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20080601
Title: GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
Journal: Basic research in cardiology 20070701
Title: Chronic preconditioning: a novel approach for cardiac protection.
Journal: American journal of physiology. Heart and circulatory physiology 20070501
Title: The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070201
Title: Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning.
Journal: American journal of physiology. Heart and circulatory physiology 20060601
Title: Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria.
Journal: Brain research bulletin 20050730
Title: Mitochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarction.
Journal: American journal of physiology. Heart and circulatory physiology 20050201
Title: BMS-191095, a cardioselective mitochondrial K(ATP) opener, inhibits human platelet aggregation by opening mitochondrial K(ATP) channels.
Journal: Archives of pharmacal research 20050101
Title: Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.
Journal: Journal of medicinal chemistry 20040226
Title: The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning.
Journal: Neuroreport 20040209
Title: In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effects.
Journal: The Journal of pharmacology and experimental therapeutics 20021001
Title: Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats.
Journal: Cardiovascular research 20020815
Title: Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemia.
Journal: Cardiovascular drug reviews 20020101
Title: Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Journal: The Journal of pharmacology and experimental therapeutics 20010601
Title: Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Journal: Journal of medicinal chemistry 20010524
Title: Katakam PV, et al. Diversity of mitochondria-dependent dilator mechanisms in vascular smooth muscle of cerebral arteries from normal and insulin-resistant rats. Am J Physiol Heart Circ Physiol. 2014 Aug 15;307(4):H493-503.
